Fenugreek for Blood Sugar and Testosterone: What Controlled Trials Show

Fenugreek (Trigonella foenum-graecum) is a Mediterranean and South Asian legume whose seeds contain galactomannan fiber, 4-hydroxyisoleucine, and steroidal saponins including protodioscin. Modern supplement marketing pulls two threads: glycemic control and "natural testosterone support." The evidence supports the first more cleanly than the second.

Glycemic effects in type 2 diabetes and prediabetes

A 2014 meta-analysis of 10 controlled trials (n=1,173) found that fenugreek seed reduced fasting plasma glucose by approximately 0.96 mmol/L (17 mg/dL) and post-prandial glucose by 2.2 mmol/L (40 mg/dL) versus placebo, with A1c reductions on the order of 0.85 percentage points after eight to 24 weeks [1]. A 2020 update with newer trials largely replicated the magnitude and noted that effects were stronger in studies using 5 g/day or more of seed powder [2]. Mechanistically, the soluble fiber slows carbohydrate absorption and 4-hydroxyisoleucine appears to enhance glucose-induced insulin secretion in islet preparations [3].

The lipid effects

The same trials report modest LDL reductions (5-10 percent) and small triglyceride decreases, consistent with bile-acid binding by the seed's high-viscosity fiber [4]. Effects on HDL are inconsistent.

The testosterone claim — read carefully

Several small industry-sponsored trials of branded fenugreek extracts (Testofen, Furosap) have reported increases in libido scores or free testosterone in men. A 2020 meta-analysis pooling four such trials found increases in total testosterone of roughly 1.6 nmol/L versus placebo over eight to 12 weeks [5]. Independent attempts have produced more equivocal results, and aromatase-inhibition mechanisms proposed for fenugreek have not been confirmed in vivo [6]. Effects on objective endpoints like sperm parameters, muscle mass, or fertility are not robustly supported.

Side effects and drug interactions

The most reliable adverse event is a maple-syrup-like body odor caused by sotolon excretion — harmless but disconcerting. Fenugreek can cause symptomatic hypoglycemia when added to sulfonylureas or insulin, may modestly enhance the anticoagulant effect of warfarin, and is contraindicated in pregnancy (uterine stimulation in animal studies) [7]. Anyone on diabetes medication should adjust dosing with their prescriber.

Lactation and prolactin: the milk-supply claim

Fenugreek is one of the most-used "galactagogues" — supplements promoted to increase breast milk supply. A 2018 systematic review of five RCTs in postpartum mothers found that fenugreek modestly increased milk volume in two trials and showed no effect in three, with overall low-quality evidence [8]. The American Academy of Pediatrics and lactation organizations consider the milk-supply benefit unproven and note that fenugreek transfers to breast milk and may flavor it; rare maple-syrup-urine disease has been mimicked diagnostically in infants of fenugreek-using mothers.

Practical guidance

Fenugreek at 5-15 g/day of seed powder or equivalent standardized extract is a reasonable adjunct for adults with prediabetes or mild type 2 diabetes who tolerate the GI effects and accept the body-odor change. The testosterone claim is best treated as marginal and unreplicated outside small industry-sponsored trials. Pregnancy is a clear contraindication. Patients on warfarin, sulfonylureas, or insulin should not add fenugreek without prescriber awareness and lab monitoring.

One additional consideration: many "testosterone boosters" combine fenugreek with zinc, magnesium, vitamin D, and DAA, making it hard for consumers to assess what (if anything) is driving any subjective benefit. Single-ingredient fenugreek trials produce smaller effect sizes than the combination-product marketing claims, and stacking ingredients often introduces costs and interactions without proportionate additional benefit.